Medtechs Must Reflect On China Localization Policies As VBP Expands

17 Apr 2024

China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.

China's volume-based procurement (VBP) scheme is already in its fourth round for medical devices – and 10th round for pharma – and companies affected by these price-cutting schemes should be preparing their growth strategies locally.

That was the advice of Hua Su, life science and healthcare practice leader and partner at Ernest & Young Parthenon,...